Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19856233 | 0.93 | TSHR (0.34) | TSHRCYP2C9RAB9AALDH1A1LMNA | |
| SCHEMBL19854713 | 0.88 | TSHR (0.35) | TSHRCYP2C9RAB9AALDH1A1LMNA | |
| SCHEMBL21398409 | 0.88 | CYP2C9 (0.37) | TSHRCYP2C9RAB9AALDH1A1LMNA | |
| SCHEMBL19854300 | 0.88 | CYP2C9 (0.31) | CYP2C9 | |
| SCHEMBL19856079 | 0.86 | TSHR (0.39) | TSHRCYP2C9RAB9AALDH1A1LMNA | |
| SCHEMBL19853969 | 0.85 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19854265 | 0.84 | CYP2C9 (0.32) | CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19855707 | 0.84 | TSHR (0.37) | TSHRCYP2C9RAB9AALDH1A1LMNA | |
| SCHEMBL21398717 | 0.83 | TSHR (0.38) | TSHRCYP2C9RAB9AALDH1A1LMNA | |
| SCHEMBL19855620 | 0.83 | CYP2C9 (0.33) | TSHRCYP2C9RAB9AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, PYM1, MPEG1 | TSHR 3095/4885CYP2C9 4670/4885RAB9A 4015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.